Skip to Main Content

Paper Details

Clinical and biochemical improvement with galactose supplementation in SLC35A2-CDG.
Genet Med
37
2020
CDG, CONCLUSIONS Oral D, D-galactose, Galactose, Golgi UDP-galactose transporter, Patients, SLC35A2, SLC35A2-CDG, UDP, Xp11, congenital disorder of glycosylation, developmental disability, dysmorphism, epilepsy, epileptic encephalopathy, galactose, galactose deficiency, gastrointestinal symptoms, growth deficiency, patient, patients
Author NameAffiliation
Fernando ScagliaBaylor College of Medicine
Fernando ScagliaTexas Children's Hospital
Fernando ScagliaPrince of Wales Hospital
Andrew C EdmondsonChildren's Hospital of Philadelphia
Miao HeChildren's Hospital of Philadelphia
  • 1 - 5

Datasets

Release 1.2